Trials / Completed
CompletedNCT05526976
PERIoperative Holistic RIsk Factor SCreening in the Prevention of Persistent Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 660 (actual)
- Sponsor
- University Hospital, Antwerp · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Assessment and management for improved wellbeing after elective surgery (PERISCOP³E-Care) Diagnostic assessment tool evaluation and cut-off determination for participation in a transmural perioperative care program
Detailed description
Adult patients (≥ 18y) who are planned to undergo an elective surgery at the University Hospital Antwerp, will be invited to participate. After signing the informed consent, they will be asked to complete questionnaires (PERISCOP3E-care; Kalkman \& modified-Althaus, DN4, HADS, Stait-trait, NRS, MPIn EQ-5D-5L) that involve screening of the risk to develop persistend postoperative pain (PPSP). The questionnaires will be completed via a survey link to the RedCap platform. Invites will be send out via the patient's e-mail. Demograpic data and relevant medical history, surgery history, concomitant medication will be registered. one month and three months post surgery the patients will be contacted to identicate if they developed PPSP. They will also be asked to complete quesionnaires (MPI, HADS, Stai-Trait, NRS, MPI, DN4). Based on this info, the cut-off value will be defined for the preoperative questionnaire. Analysis will be done for the sensitivity and specificity of the questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PERISCOPE-care | Patients with planned elective surgery will be asked to complete the PERISCOP3E-Care questionnaire (modified-Althaus \& Kalkman, DN4, HADS, Stait-trait, NRS, MPI, EQ-5D-5L) preoperative. One month and three months post op the patients will be contacted to check if they developed persistend postoperative pain and they will also complete questionnaires (DN4, HADS, Stait-trait, NRS, MPI and EQ-5D-5L). |
Timeline
- Start date
- 2022-12-22
- Primary completion
- 2024-03-06
- Completion
- 2024-03-06
- First posted
- 2022-09-02
- Last updated
- 2024-06-10
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05526976. Inclusion in this directory is not an endorsement.